These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7958725)

  • 21. A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs.
    Takayanagi I; Koike K
    Gen Pharmacol; 1985; 16(3):265-7. PubMed ID: 2862092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the beta-adrenoceptor affinity and selectivity of cetamolol, atenolol, betaxolol, and ICI-118,551.
    Rimele TJ; Henry DE; Giesa FR; Buckley SK; Geiger G; Heaslip RJ; Lee DK; Grimes D
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):208-17. PubMed ID: 2459552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of clenbuterol are beta 2-adrenoceptor-mediated in steers.
    Hoey AJ; Matthews ML; Badran TW; Pegg GG; Sillence MN
    J Anim Sci; 1995 Jun; 73(6):1754-65. PubMed ID: 7673070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac beta(1)- or beta(2)-adrenoceptors.
    Whalen EJ; Lewis SJ
    Eur J Pharmacol; 1999 Oct; 382(3):207-10. PubMed ID: 10556671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological studies of celiprolol: I. Beta-blocking effect, intrinsic sympathomimetic activity, vasodilating and hypotensive effects].
    Miura A; Kimura Y; Inoue K; Matsuzaki T; Ochi S; Hamada K; Hayashi S; Tamura M; Kano S; Kimura K
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):191-200. PubMed ID: 1973398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.
    Kaumann AJ; Lemoine H
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):27-39. PubMed ID: 2866449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
    Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
    Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
    Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guaiacoxypropanolamine derivatives of capsaicin: a new family of beta-adrenoceptor blockers with intrinsic cardiotonic properties.
    Chen IJ; Yeh JL; Liou SJ; Shen AY
    J Med Chem; 1994 Apr; 37(7):938-43. PubMed ID: 7908697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug effects on blood pressure and heart rate in unanesthetized animals. (1). Effects of beta-blocking agents (author's transl)].
    Iizuka H; Nakagawa Y; Matsubara I; Imai S; Yanagita T
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):401-9. PubMed ID: 20392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.
    Brawley L; Shaw AM; MacDonald A
    Br J Pharmacol; 2000 Feb; 129(4):637-44. PubMed ID: 10683187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selectivity of the intrinsic sympathomimetic activity of the beta-adrenergic blocking drug bucindolol.
    Leff AR; Garrity ER; Munoz NM; Tallet J; Cavigelli M; Deitchman D; Rajfer SI
    J Cardiovasc Pharmacol; 1984; 6(5):859-66. PubMed ID: 6209492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influences of beta-blocking agents on cardiovascular actions induced by endothelin-3 administered intracerebroventricularly in anesthetized rats.
    Ono N; Kaneko M
    Life Sci; 1995; 57(4):345-53. PubMed ID: 7603307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of celiprolol.
    Louis WJ; Drummer OH; Tung LH
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).
    Bilski AJ; Halliday SE; Fitzgerald JD; Wale JL
    J Cardiovasc Pharmacol; 1983; 5(3):430-7. PubMed ID: 6191142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits.
    Gan LL; Wang MW; Cheng MS; Pan L
    Biol Pharm Bull; 2003 Mar; 26(3):323-8. PubMed ID: 12612441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.